» Articles » PMID: 37112935

Seroprevalence of IgG and Subclasses Against the Nucleocapsid of SARS-CoV-2 in Health Workers

Abstract

Background: The nucleocapsid protein of SARS-CoV-2 participates in viral replication, transcription, and assembly. Antibodies against this protein have been proposed for the epidemiological analysis of the seroprevalence of COVID-19 associated with natural infection by SARS-CoV-2. Health workers were one of the most exposed populations, and some had an asymptomatic form of the disease, so detecting IgG antibodies and subclasses against the N protein can help to reclassify their epidemiological status and obtain information about the effector mechanisms associated with viral elimination.

Methods: In this study, we analyzed 253 serum samples collected in 2021 and derived from health workers, and evaluated the presence of total IgG and subclasses against the N protein of SARS-CoV-2 by indirect ELISA.

Results: From the analyzed samples, 42.69% were positive to anti-N IgG antibodies. A correlation between COVID-19 asymptomatic infection and IgG antibodies was observed ( = 0.006). The detected subclasses were: IgG1 (82.4%), IgG2 (75.9%), IgG3 (42.6%), and IgG4 (72.6%).

Conclusions: This work provides evidence about the high seroprevalence of total IgG and subclasses of anti-N and their relations with the asymptomatic infection of SARS-CoV-2 and related symptoms.

Citing Articles

Acute neutrophilic vasculitis (leukocytoclasia) in 36 COVID-19 autopsy brains.

Rhodes R, Love G, Da Silva Lameira F, Sadough Shahmirzadi M, Fox S, Vander Heide R Diagn Pathol. 2024; 19(1):33.

PMID: 38360666 PMC: 10870569. DOI: 10.1186/s13000-024-01445-w.

References
1.
Whitcombe A, McGregor R, Craigie A, James A, Charlewood R, Lorenz N . Comprehensive analysis of SARS-CoV-2 antibody dynamics in New Zealand. Clin Transl Immunology. 2021; 10(3):e1261. PMC: 7955949. DOI: 10.1002/cti2.1261. View

2.
Burbelo P, Riedo F, Morishima C, Rawlings S, Smith D, Das S . Sensitivity in Detection of Antibodies to Nucleocapsid and Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Coronavirus Disease 2019. J Infect Dis. 2020; 222(2):206-213. PMC: 7313936. DOI: 10.1093/infdis/jiaa273. View

3.
Chan J, Kok K, Zhu Z, Chu H, To K, Yuan S . Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect. 2020; 9(1):221-236. PMC: 7067204. DOI: 10.1080/22221751.2020.1719902. View

4.
de Taeye S, Rispens T, Vidarsson G . The Ligands for Human IgG and Their Effector Functions. Antibodies (Basel). 2019; 8(2). PMC: 6640714. DOI: 10.3390/antib8020030. View

5.
Kim D, Lee J, Yang J, Kim J, Kim V, Chang H . The Architecture of SARS-CoV-2 Transcriptome. Cell. 2020; 181(4):914-921.e10. PMC: 7179501. DOI: 10.1016/j.cell.2020.04.011. View